story of the week
Use of Semaglutide for the Primary Prevention of Diabetic Kidney Disease in People With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of semaglutide on primary prevention of diabetic kidney disease in people with type 2 diabetes: A post hoc analysis of the SUSTAIN 6 randomized controlled trial
Diabetes Obes Metab 2024 Aug 27;[EPub Ahead of Print], J Wang, J Yang, W Jiang, W Liu, Z Shen, Z Gao, B ChangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.